Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Beguin

Showing results (71-80 of 242) with videos related to

Pageof 25
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 2, 2025
Whipple's disease presenting with bone marrow findings mimicking prefibrotic myelofibrosis: A diagnostic pitfallGaëlle Vertenoeil, Kaoutar Hafraoui, Patrick Collins, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2010
High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008)Natacha Verbeke, Yves Beguin, Hans Wildiers, et al.
Blood|May 23, 2014
Erythropoietin therapy after allogeneic hematopoietic cell transplantation: a prospective, randomized trialAurélie Jaspers, Frédéric Baron, Evelyne Willems, et al.
Haematologica|January 22, 2002
Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantationFrédéric Baron, Jean Siquet, Nicole Schaaf-Lafontaine, et al.
Bone Marrow Transplantation|March 5, 2021
High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantationCaroline Ritacco, Grégory Ehx, Céline Grégoire, et al.
Experimental Hematology|June 27, 2006
Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor responseGaëtan Vanstraelen, Frédéric Baron, Evelyne Willems, et al.
Transplantation|January 14, 2020
Mesenchymal Stromal Cells in Solid Organ TransplantationMorgan Vandermeulen, Pauline Erpicum, Laurent Weekers, et al.
Frontiers in Immunology|November 16, 2020
How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-<i>Versus</i>-Host Disease Prevention After Allogeneic Hematopoietic Cell TransplantationBenoît Vandenhove, Lorenzo Canti, Hélène Schoemans, et al.
Haematologica|January 21, 2014
Serum hepcidin following autologous hematopoietic cell transplantation: an illustration of the interplay of iron status, erythropoiesis and inflammationAurélie Jaspers, Frédéric Baron, Evelyne Willems, et al.
Revue Medicale De Liege|February 15, 2024
[Is there a place for granulocytes transfusions in 2023 ?]Adrien Barzin, Claire Maquet, Anaïs Devey, et al.
Pageof 25

Showing results (71-80 of 242) with videos related to

Sort By:
Pageof 25
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 2, 2025
Whipple's disease presenting with bone marrow findings mimicking prefibrotic myelofibrosis: A diagnostic pitfallGaëlle Vertenoeil, Kaoutar Hafraoui, Patrick Collins, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 26, 2010
High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008)Natacha Verbeke, Yves Beguin, Hans Wildiers, et al.
Blood|May 23, 2014
Erythropoietin therapy after allogeneic hematopoietic cell transplantation: a prospective, randomized trialAurélie Jaspers, Frédéric Baron, Evelyne Willems, et al.
Haematologica|January 22, 2002
Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantationFrédéric Baron, Jean Siquet, Nicole Schaaf-Lafontaine, et al.
Bone Marrow Transplantation|March 5, 2021
High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantationCaroline Ritacco, Grégory Ehx, Céline Grégoire, et al.
Experimental Hematology|June 27, 2006
Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor responseGaëtan Vanstraelen, Frédéric Baron, Evelyne Willems, et al.
Transplantation|January 14, 2020
Mesenchymal Stromal Cells in Solid Organ TransplantationMorgan Vandermeulen, Pauline Erpicum, Laurent Weekers, et al.
Frontiers in Immunology|November 16, 2020
How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-<i>Versus</i>-Host Disease Prevention After Allogeneic Hematopoietic Cell TransplantationBenoît Vandenhove, Lorenzo Canti, Hélène Schoemans, et al.
Haematologica|January 21, 2014
Serum hepcidin following autologous hematopoietic cell transplantation: an illustration of the interplay of iron status, erythropoiesis and inflammationAurélie Jaspers, Frédéric Baron, Evelyne Willems, et al.
Revue Medicale De Liege|February 15, 2024
[Is there a place for granulocytes transfusions in 2023 ?]Adrien Barzin, Claire Maquet, Anaïs Devey, et al.
Pageof 25